Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Monkeypox Virus Immune Evasion and Eye Manifestation: Beyond Eyelid Implications

2023; Multidisciplinary Digital Publishing Institute; Volume: 15; Issue: 12 Linguagem: Inglês

10.3390/v15122301

1999-4915

Francisco Dias Lucena‐Neto, Luiz Fábio Magno Falcão, Adolfo S. Vieira-Junior, Evelly C. S. Moraes, Joacy Pedro Franco David, Camilla Costa Silva, Jorge Rodrigues de Sousa, Maria Irma Seixas Duarte, Pedro Fernando da Costa Vasconcelos, Juarez Antônio Simões Quaresma,

Immunotherapy and Immune Responses

Monkeypox virus (MPXV), belonging to the Poxviridae family and Orthopoxvirus genus, is closely related to the smallpox virus. Initial prodromal symptoms typically include headache, fever, and lymphadenopathy. This review aims to detail various ocular manifestations and immune evasion associated with the monkeypox viral infection and its complications, making it appropriate as a narrative review. Common external ocular manifestations of MPXV typically involve a generalized pustular rash, keratitis, discharges, and dried secretions related to conjunctival pustules, photophobia, and lacrimation. Orthopoxviruses can evade host immune responses by secreting proteins that antagonize the functions of host IFNγ, CC and CXC chemokines, IL-1β, and the complement system. One of the most important transcription factors downstream of pattern recognition receptors binding is IRF3, which controls the expression of the crucial antiviral molecules IFNα and IFNβ. We strongly recommend that ophthalmologists include MPXV as part of their differential diagnosis when they encounter similar cases presenting with ophthalmic manifestations such as conjunctivitis, blepharitis, or corneal lesions. Furthermore, because non-vaccinated individuals are more likely to exhibit these symptoms, it is recommended that healthcare administrators prioritize smallpox vaccination for at-risk groups, including very young children, pregnant women, older adults, and immunocompromised individuals, especially those in close contact with MPXV cases.